These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 22836615

  • 1. Indacaterol add-on therapy improves lung function, exercise capacity and life quality of COPD patients.
    Mroz RM, Minarowski L, Chyczewska E.
    Adv Exp Med Biol; 2013; 756():23-8. PubMed ID: 22836615
    [Abstract] [Full Text] [Related]

  • 2. Indacaterol therapy in moderate-to-severe chronic obstructive pulmonary disease: findings from a single-center primary care cohort.
    Singh MP.
    Int J Chron Obstruct Pulmon Dis; 2013; 8():613-9. PubMed ID: 24353411
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of indacaterol on dynamic lung hyperinflation and breathlessness in hyperinflated patients with COPD.
    Beeh KM, Wagner F, Khindri S, Drollmann AF.
    COPD; 2011 Oct; 8(5):340-5. PubMed ID: 21793716
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of tiotropium and indacaterol monotherapy and their combination on dynamic lung hyperinflation in COPD: a random open-label crossover study.
    Fujimoto K, Yamazaki H, Ura M, Kitaguchi Y.
    Int J Chron Obstruct Pulmon Dis; 2017 Oct; 12():3195-3201. PubMed ID: 29138547
    [Abstract] [Full Text] [Related]

  • 7. FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease.
    Mahler DA, Kerwin E, Ayers T, FowlerTaylor A, Maitra S, Thach C, Lloyd M, Patalano F, Banerji D.
    Am J Respir Crit Care Med; 2015 Nov 01; 192(9):1068-79. PubMed ID: 26177074
    [Abstract] [Full Text] [Related]

  • 8. Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease.
    Nishijima Y, Minami S, Yamamoto S, Ogata Y, Koba T, Futami S, Komuta K.
    Int J Chron Obstruct Pulmon Dis; 2015 Nov 01; 10():439-44. PubMed ID: 25767381
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD.
    Dahl R, Chung KF, Buhl R, Magnussen H, Nonikov V, Jack D, Bleasdale P, Owen R, Higgins M, Kramer B, INVOLVE (INdacaterol: Value in COPD: Longer Term Validation of Efficacy and Safety) Study Investigators.
    Thorax; 2010 Jun 01; 65(6):473-9. PubMed ID: 20522841
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical role of dual bronchodilation with an indacaterol-glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of life.
    Rossi A, Zanardi E, Poletti V, Cazzola M.
    Int J Chron Obstruct Pulmon Dis; 2015 Jun 01; 10():1383-92. PubMed ID: 26229457
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
    Kerwin EM, Gotfried MH, Lawrence D, Lassen C, Kramer B.
    Clin Ther; 2011 Dec 01; 33(12):1974-84. PubMed ID: 22177371
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of indacaterol on quality of life and pulmonary function in patients with COPD and inhaler device preferences.
    Ohno T, Wada S, Hanada S, Sawaguchi H, Muraki M, Tohda Y.
    Int J Chron Obstruct Pulmon Dis; 2014 Dec 01; 9():107-14. PubMed ID: 24489464
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of Adding Tiotropium or Aclidinium as Triple Therapy Using Impulse Oscillometry in COPD.
    Manoharan A, Morrison AE, Lipworth BJ.
    Lung; 2016 Apr 01; 194(2):259-66. PubMed ID: 26758884
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.